1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Animal/Veterinary Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot & Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] – Global Forecast to 20

The global animal vaccines market is in its growth phase and is estimated to be worth $5.8 billion in 2013. It is expected to grow at a healthy CAGR of 8.1% to reach $8.6 billion by 2018. The animal vaccines market is segmented on the basis of products, animal diseases, and technologies that are involved in developing vaccines for veterinary administration. The global animal vaccines market, by products, is further segmented into seven segments, namely, companion animal vaccines, livestock, poultry, porcine, equine, aquaculture, and other animal vaccines. In 2012, livestock vaccines and porcine vaccines were two of the largest segments, which accounted for 63% of the market share, globally. The livestock vaccines market is further segmented into bovine vaccines and small ruminant vaccines, whereas the companion animal vaccines market is further segmented into canine vaccines and feline vaccines.

By technology, the animal vaccines market is segmented on the basis of live attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. DNA vaccines demonstrate tremendous growth opportunities due to factors such as added thermo-stability, cost effectiveness, easy production, and rapid development against emerging diseases.

The factors responsible for the growth of the animal vaccine market include increasing incidences of zoonotic diseases in humans, growing prevalence of animal diseases, and increasing investments by government bodies, animal welfare associations, and leading players. Another factor that drives the growth in this space is the continuous innovations and introduction of new products in the market. Since 2012, more than 20 new products have been launched, presenting a huge potential for growth in this arena. However, increasing maintenance costs for vaccines and the shift towards vegetarian food by consumers will restrict the growth of the market to a certain extent. With the growing awareness of animal health in emerging economies, new entrants as well as established players have huge opportunities to introduce novel vaccines such as DNA and recombinant vaccines and to enter emerging countries.

Europe accounts for the largest share of the animal vaccines market, followed by North America. Both markets are reaching the maturity phase of their growth process, and will register mid single-digit growth rates for the next five years. The developing regions that include Asia, parts of Africa, and LATAM are expected to form the new revenue pockets for this market. These regions are poised to double their growth rates owing to the increasing investment opportunities for companies in these immature markets and the improving healthcare facilities for animals. Countries such as China, India, Australia, and Brazil will be major contributors to the growth of the market.

To encash the favorable conditions in developing economies and to stay ahead of the competition in the global market, a number of tier-I companies are investing in these countries. For instance, in April 2013, Lohmann Animal Health invested about $100 million to set up a poultry vaccine manufacturing plant in Taiwan.

Owing to high growth prospects in the aquaculture, companion, and equine vaccine which are estimated to double their growth rates during the forecast period, will observe huge investments in these segments from major players. For example in late 2011, Pfizer Animal Health invested $75 million to open an R&D centre in the U.S.

The market is dominated by tier I players and is fairly consolidated with the top five players contributing close to 70% of the share. New entrants face high barriers in entering this market as it is a capital-intensive industry with strict regulations. The major players in the global animal vaccines market are Pfizer (Zoetis) (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada Inc. (Canada), and Ceva (France).

New product launches, agreements, partnerships, collaborations, along with joint ventures are the two most preferred strategies, followed by the key players. The industry giants adopted these strategies to enhance their product offerings, to increase their market shares, to meet the customer need, and to consolidate their market presence. In addition, companies such as Heska Corporation, Bayer Healthcare, and Merial Animal Health, focus on mergers & acquisition to gain an edge in the competition. For instance, in December 2012, Merial (Animal health division of Sanofi) acquired the animal health division of Dosch Pharmaceuticals Pvt. Ltd., to enter the emerging Indian Animal Health market.

Table Of Contents

Animal/Veterinary Vaccines Market [Products (Livestock - Bovine, Companion - Canine, Poultry, Equine), Diseases (Rabies, Distemper, Foot and Mouth, Gumboro, Avian Influenza, Strangles), Technology (Live attenuated, DNA, Recombinant)] - Global Forecast to 20
TABLE OF CONTENTS


1 INTRODUCTION 22

1.1 KEY TAKE-AWAYS 22
1.2 REPORT DESCRIPTION 22
1.3 RESEARCH METHODOLOGY 23
1.3.1 MARKET SIZE ESTIMATION 23
1.3.2 MARKET SHARE 26
1.3.3 KEY DATA POINTS FROM SECONDARY SOURCES 27
1.3.4 KEY DATA POINTS FROM PRIMARY SOURCES 27
1.3.5 ASSUMPTIONS 28
1.4 MARKETS COVERED 29
1.5 STAKEHOLDERS 32
1.6 MARKET SCOPE 32

2 EXECUTIVE SUMMARY 33

3 MARKET OVERVIEW 37

3.1 INTRODUCTION 38
3.2 MARKET SEGMENTATION 38
3.3 MARKET DYNAMICS 40
3.3.1 DRIVERS 40
3.3.1.1 Growing Prevalence of Animal Diseases will Result in Employing Preventive Measures Like Vaccines 40
3.3.1.2 Increasing Incidences of Zoonotic Diseases in Humans will Propel the Vaccines Market 41
3.3.1.3 Increasing Investments by Various Government Agencies, Animal Associations, and Leading Players to Propel the Market 42
3.3.1.4 Continuous Innovations and Introduction of New Products Propels the Market 43

3.3.2 RESTRAINTS 44
3.3.2.1 Rising Maintenance Costs for Storage of Vaccines, a Burden on Manufacturers and Distributors 44
3.3.2.2 Increasing Adoption of Vegetarian Food in Major Economies Owing to Increasing Risk of Obesity and other Chronic Disorders 44
3.3.2.3 Persistent Economic Slowdown to Affect Growth 45
3.3.3 OPPORTUNITIES 45
3.3.3.1 Technological Innovations like DNA Vaccines 45
3.3.3.2 Growing Awareness of Animal Health in Emerging Economies 46
3.3.3.3 Increasing Investment Opportunities in Emerging and Immature Markets 47
3.4 REGULATIONS FOR ANIMAL VACCINES 48
3.4.1 USDA REGULATES THE REGISTRATION PROCESS IN U.S. 48
3.4.2 EMEA IS THE APEX BODY FOR APPROVAL OF VETERINARY VACCINES IN EUROPE 48
3.4.3 MAFF REGULATES THE VETERINARY MEDICINAL PRODUCTS (VMPS) IN JAPAN 49
3.4.4 VICH HARMONIZES THE REGISTRATION PROCESS IN U.S., EUROPE AND JAPAN 49
3.5 PORTER'S FIVE FORCES ANALYSIS 50
3.5.1 THREAT FROM NEW ENTRANTS 51
3.5.2 THREAT FROM SUBSTITUTES 51
3.5.3 BARGAINING POWER OF BUYERS 51
3.5.4 BARGAINING POWER OF SUPPLIERS 51
3.5.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS 51
3.6 MARKET SHARE ANALYSIS 52
3.6.1 GLOBAL 52
3.6.2 NORTH AMERICA 55
3.6.3 EUROPE 56
3.6.4 ASIA 57

4 GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT 58

4.1 INTRODUCTION 59
4.2 COMPANION ANIMAL VACCINES 60
4.2.1 CANINE VACCINES CONTRIBUTE THE LARGEST TO THE COMPANION ANIMAL VACCINES MARKET 61
4.2.2 CANINE VACCINES 62
4.2.3 FELINE VACCINES 63
4.3 LIVESTOCK VACCINES 63
4.3.1 INCREASING INVESTMENTS BY GOVERNMENT BODIES AND COMPANIES 64
4.3.2 BOVINE VACCINES 65
4.3.3 SMALL RUMINANT VACCINES 66
4.4 POULTRY VACCINES 66
4.5 PORCINE VACCINES 68
4.6 EQUINE VACCINES 69
4.7 AQUACULTURE VACCINES 70
4.7.1 AQUACULTURE VACCINES MARKET TO GROW AT THE FASTEST PACE 70
4.8 OTHER ANIMAL VACCINES 71

5 GLOBAL ANIMAL VACCINES MARKET, BY DISEASE 72

5.1 INTRODUCTION 73
5.2 COMPANION ANIMAL VACCINES 73
5.2.1 CANINE VACCINES, BY DISEASE 73
5.2.1.1 Canine Rabies 74
5.2.1.2 Canine Distemper 75
5.2.1.3 Canine Parvovirus 76
5.2.1.4 Infectious Canine Hepatitis 76
5.2.2 FELINE VACCINES, BY DISEASE 77
5.2.2.1 Feline Rabies 78
5.2.2.2 Feline Panleukopenia 78
5.2.2.3 Feline Viral Rhinotracheitis 79
5.2.2.4 Feline Leukemia 80
5.3 LIVESTOCK VACCINES 80
5.3.1 BOVINE VACCINES, BY DISEASE 81
5.3.1.1 Foot and Mouth Disease (FMD) 82
5.3.1.2 Bovine Viral Diarrhea 83
5.3.1.3 Bovine Clostridial Diseases 83
5.3.1.4 Brucellosis 84
5.3.1.5 Infectious Bovine Rhinotracheitis 84
5.3.2 SMALL RUMINANT VACCINES, BY DISEASE 85
5.3.2.1 Small Ruminant Clostridial Diseases 86
5.3.2.2 Scabby Mouth Infection 87
5.3.2.3 Pneumonia and Septicemia 87
5.3.2.4 Pox Diseases 88
5.3.2.5 Ovine Johne's Disease (Paratuberculosis) 89
5.4 POULTRY VACCINES, BY DISEASE 89
5.4.1 INFECTIOUS BRONCHITIS 90
5.4.2 GUMBORO DISEASE 91
5.4.3 AVIAN INFLUENZA 92
5.4.4 COCCIDIOSIS 93
5.4.5 MAREK'S DISEASE 94
5.4.6 NEWCASTLE DISEASE 95
5.5 PORCINE VACCINES, BY DISEASE 97
5.5.1 PORCINE PARVOVIRUS 98
5.5.2 PORCINE REPRODUCTIVE RESPIRATORY SYNDROME (PRRS) 98
5.5.3 PORCINE CIRCOVIRUS II 99
5.5.4 SWINE INFLUENZA 100
5.5.5 SWINE PNEUMONIA 100
5.6 EQUINE VACCINES, BY DISEASE 101
5.6.1 EQUINE ENCEPHALOMYELITIS 102
5.6.2 STRANGLES 102
5.6.3 EQUINE INFLUENZA (HORSE FLU) 103
5.6.4 EQUINE RHINOPNEUMONITIS 103
5.7 AQUACULTURE VACCINES, BY DISEASE 104
5.7.1 VIBRIOSIS 105
5.7.2 PASTEURELLOSIS 105
5.7.3 FURUNCULOSIS 106

6 ANIMAL VACCINE MARKET, BY TECHNOLOGY 107

6.1 INTRODUCTION 108
6.2 LIVE ATTENUATED VACCINES (LAV) 109
6.3 INACTIVATED VACCINES 109
6.4 SUBUNIT VACCINES 110
6.5 TOXOID VACCINES 111
6.6 CONJUGATE VACCINES 111
6.7 RECOMBINANT VACCINES 112
6.8 DNA VACCINES 112
6.9 LIVE ATTENUATED TECHNOLOGY CONTRIBUTES THE LARGEST TO THE LIVESTOCK VACCINES MARKET 114
6.10 DNA VACCINES ALONG WITH INACTIVATED and RECOMBINANT TECHNOLOGY TO GROW AT HEALTHY PACE 115
6.11 INACTIVATED VACCINES TECHNOLOGY ACCOUNTS FOR THE LARGEST SHARE IN PORCINE VACCINE MARKET 116

7 GEOGRAPHIC ANALYSIS 119

7.1 INTRODUCTION 120
7.2 EUROPE 122
7.2.1 EUROPE DOMINATES THE ANIMAL VACCINE MARKET OWING TO HIGHLY ORGANIZED LIVESTOCK SECTOR 122
7.3 NORTH AMERICA 140
7.3.1 RISE IN COMPANION and FARM ANIMALS TO DRIVE THE NORTH AMERICAN MARKET 140
7.3.2 INCREASE IN INVESTMENTS BY COMPANIES IN NORTH AMERICA 140
7.4 ASIA 158
7.4.1 ASIAN COUNTRIES OFFER HUGE OPPORTUNITIES TO VACCINE MANUFACTURERS 158
7.5 REST OF THE WORLD (ROW) 176

8 COMPETITIVE LANDSCAPE 194

8.1 INTRODUCTION 194
8.1.1 MORE THAN 20 NEW PRODUCTS WERE LAUNCHED BETWEEN 2012 and 2013 195
8.2 MERGERS and ACQUISITIONS 196
8.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, and JOINT VENTURES 198
8.4 NEW PRODUCT LAUNCH 199
8.5 OTHER DEVELOPMENTS 204

9 COMPANY PROFILES 207

9.1 BAYER HEALTHCARE 207
9.2 BIOGENESIS BAGO S.A. 213
9.3 BIONICHE ANIMAL HEALTH CANADA, INC. 215
9.4 BOEHRINGER INGELHEIM 219
9.5 CEVA (CEVA SANTE ANIMALE) 224
9.6 HESKA CORPORATION 228
9.7 INDIAN IMMUNOLOGICALS LTD. 232
9.8 LOHMANN ANIMAL HEALTH INTERNATIONAL 236
9.9 MERCK 241
9.10 MERIAL (ANIMAL HEALTH DIVISION OF SANOFI) 255
9.11 NOVARTIS ANIMAL HEALTH, INC. 259
9.12 PROTEIN SCIENCES CORPORATION 264
9.13 VIRBAC 266
9.14 ZOETIS (PFIZER ANIMAL HEALTH) 271


LIST OF TABLES

TABLE 1 GLOBAL VETERINARY VACCINES MARKET, BY PRODUCT,
2011 - 2018 ($MILLION) 35
TABLE 2 GLOBAL COMPANION ANIMAL VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 61
TABLE 3 COMPANION ANIMAL VACCINES MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 62
TABLE 4 GLOBAL LIVESTOCK VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 64
TABLE 5 LIVESTOCK VACCINES MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 65
TABLE 6 POULTRY VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 67
TABLE 7 PORCINE VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 68
TABLE 8 EQUINE VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 69
TABLE 9 AQUACULTURE VACCINES MARKET, BY GEOGRAPHY,
2011 - 2018 ($MILLION) 70
TABLE 10 OTHER VACCINES MARKET, BY GEOGRAPHY, 2011 - 2018 ($MILLION) 71
TABLE 11 GLOBAL CANINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 74
TABLE 12 GLOBAL FELINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 77
TABLE 13 GLOBAL BOVINE VACCINES MARKET, BY DISEASE,
2011 -2018 ($MILLION) 82
TABLE 14 GLOBAL SMALL RUMINANT VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 86
TABLE 15 GLOBAL POULTRY VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 90
TABLE 16 COMMERCIALLY USED STRAIN FOR AVIAN INFLUENZA VACCINES 93
TABLE 17 COMMERCIALLY USED STRAIN FOR NEWCASTLE DISEASE VACCINES 96
TABLE 18 GLOBAL PORCINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 97
TABLE 19 GLOBAL EQUINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 101
TABLE 20 GLOBAL AQUACULTURE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 104
TABLE 21 GLOBAL COMPANION ANIMAL VACCINE MARKET, BY TECHNOLOGY, 2011 - 2018 ($MILLION) 113
TABLE 22 GLOBAL LIVESTOCK VACCINE MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 114
TABLE 23 GLOBAL POULTRY VACCINE MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 115
TABLE 24 GLOBAL PORCINE VACCINE MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 116
TABLE 25 GLOBAL EQUINE VACCINE MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 117
TABLE 26 GLOBAL AQUACULTURE VACCINE MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 118
TABLE 27 NUMBER OF CATTLE IN EUROPE, 2010 and 2011 (THOUSAND HEAD) 122
TABLE 28 EUROPE: VETERINARY VACCINES MARKET, BY PRODUCT,
2011 - 2018 ($MILLION) 123
TABLE 29 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY, 2011 - 2018 ($MILLION) 124
TABLE 30 EUROPE: CANINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 125
TABLE 31 EUROPE: FELINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 126
TABLE 32 EUROPE: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY, 2011 - 2018 ($MILLION) 127
TABLE 33 EUROPE: LIVESTOCK VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 128
TABLE 34 EUROPE: BOVINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 129
TABLE 35 EUROPE: SMALL RUMINANT VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 130
TABLE 36 EUROPE: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 131
TABLE 37 EUROPE: POULTRY VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 132
TABLE 38 EUROPE: POULTRY VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 133
TABLE 39 EUROPE: PORCINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 134
TABLE 40 EUROPE: PORCINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 135
TABLE 41 EUROPE: EQUINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 136
TABLE 42 EUROPE: EQUINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 137
TABLE 43 EUROPE: AQUACULTURE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 138
TABLE 44 EUROPE: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 139
TABLE 45 NORTH AMERICA: VETERINARY VACCINES MARKET, BY PRODUCT,
2011 - 2018 ($MILLION) 141
TABLE 46 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET,
BY CATEGORY, 2011 - 2018 142
TABLE 47 NORTH AMERICA: CANINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 143
TABLE 48 NORTH AMERICA: FELINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 144
TABLE 49 NORTH AMERICA: COMPANION ANIMAL VACCINES MARKET,
BY TECHNOLOGY, 2011 - 2018 ($MILLION) 145
TABLE 50 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 146
TABLE 51 NORTH AMERICA: BOVINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 147
TABLE 52 NORTH AMERICA: SMALL RUMINANT VACCINES MARKET,
BY DISEASE, 2011 - 2018 ($MILLION) 148
TABLE 53 NORTH AMERICA: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY, 2011 - 2018 ($MILLION) 149
TABLE 54 NORTH AMERICA: POULTRY VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 150
TABLE 55 NORTH AMERICA: POULTRY VACCINES MARKET, BY TECHNOLOGY, 2011 - 2018 ($MILLION) 151
TABLE 56 NORTH AMERICA: PORCINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 152
TABLE 57 NORTH AMERICA: PORCINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 153
TABLE 58 NORTH AMERICA: EQUINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 154
TABLE 59 NORTH AMERICA: EQUINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 155
TABLE 60 NORTH AMERICA: AQUACULTURE VACCINES MARKET, BY DISEASE, 2011 - 2018 ($MILLION) 156
TABLE 61 NORTH AMERICA: AQUACULTURE VACCINES MARKET,
BY TECHNOLOGY, 2011 - 2018 ($MILLION) 157
TABLE 62 ASIA: VETERINARY VACCINES MARKET, BY PRODUCT,
2011 - 2018 ($MILLION) 159
TABLE 63 ASIA: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 160
TABLE 64 ASIA: CANINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 161
TABLE 65 ASIA: FELINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 162
TABLE 66 ASIA: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 163
TABLE 67 ASIA: LIVESTOCK VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 164
TABLE 68 ASIA: BOVINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 165
TABLE 69 ASIA: SMALL RUMINANT VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 166
TABLE 70 ASIA: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 167
TABLE 71 ASIA: POULTRY VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 168
TABLE 72 ASIA: POULTRY VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 169
TABLE 73 ASIA: PORCINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 170
TABLE 74 ASIA: PORCINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 171
TABLE 75 ASIA: EQUINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 172
TABLE 76 ASIA: EQUINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 173
TABLE 77 ASIA: AQUACULTURE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 174
TABLE 78 ASIA: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 175
TABLE 79 ROW: VETERINARY VACCINES MARKET, BY PRODUCT,
2011 - 2018 ($BILLION) 177
TABLE 80 ROW: COMPANION ANIMAL VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 178
TABLE 81 ROW: CANINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 179
TABLE 82 ROW: FELINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 180
TABLE 83 ROW: COMPANION ANIMAL VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 181
TABLE 84 ROW: LIVESTOCK VACCINES MARKET, BY CATEGORY,
2011 - 2018 ($MILLION) 182
TABLE 85 ROW: BOVINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 183
TABLE 86 ROW: SMALL RUMINANT VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 184
TABLE 87 ROW: LIVESTOCK VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 185
TABLE 88 ROW: POULTRY VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 186
TABLE 89 ROW: POULTRY VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 187
TABLE 90 ROW: PORCINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 188
TABLE 91 ROW: PORCINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 189
TABLE 92 ROW: EQUINE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 190
TABLE 93 ROW: EQUINE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 191
TABLE 94 ROW: AQUACULTURE VACCINES MARKET, BY DISEASE,
2011 - 2018 ($MILLION) 192
TABLE 95 ROW: AQUACULTURE VACCINES MARKET, BY TECHNOLOGY,
2011 - 2018 ($MILLION) 193
TABLE 96 MERGERS and ACQUISITIONS (2011 - 2013) 196
TABLE 97 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, and JOINT VENTURES (2011 - 2013) 198
TABLE 98 NEW PRODUCT LAUNCH (2011 - 2013) 199
TABLE 99 OTHER DEVELOPMENTS (2011 - 2012) 204


List Of Figures

Figure 1 Market Size Estimation Methodology For Animal Vaccines Market, By Products
Figure 2 Market Size Estimation Methodology For Animal Vaccines Market, By Diseases And Technology
Figure 3 Data Triangulation Methodology (360o Evaluation)
Figure 4 Veterinary Vaccines Market, By Geography (%) and By Products ($Million), 2013
Figure 5 Animal Vaccines Market Segmentation
Figure 6 Market Dynamics
Figure 7 Porter's Five Forces Analysis
Figure 8 Global Market Share Analysis, By Key Players, 2012
Figure 9 North America: Animal Vaccines Market Share Analysis, By Key Players, 2012
Figure 10 Europe: Animal Vaccines Market Share Analysis, By Key Players, 2012
Figure 11 Asia: Animal Vaccines Market Share Analysis, By Key Players, 2012
Figure 12 Opportunity Matrix: Global Veterinary Vaccines Market, By Product, 2011 - 2018 ($Million)
Figure 13 Global Canine Vaccines Market, By Disease, 2013 ($Million)
Figure 14 Global Feline Vaccines Market, By Disease, 2013 ($Million)
Figure 15 Technology Evolution
Figure 16 Global LAV Market, By Product, 2013 and 2018 ($Million)
Figure 17 Animal Vaccines Market, By Geography, 2013
Figure 18 Animal Vaccines Market, Growth Phases, By Geography, 2013
Figure 19 Geographic Reach Vs Product Portfolio Analysis: Key Players
Figure 20 Key Growth Strategies, 2010 - 2013
Figure 21 Bayer Healthcare: Total Revenue ($Million) And Operating Margin (%), 2010 - 2012
Figure 22 Bayer Healthcare: Business Revenue Mix, 2012
Figure 23 Bayer Healthcare: Geographic Revenue Mix, 2012
Figure 24 Bayer Healthcare: Market Strategy, 2011 - 2013
Figure 25 Bioniche: Total Revenue ($Million), 2010 - 2012
Figure 26 Bioniche: Business Revenue Mix, 2012
Figure 27 Bioniche: Geographic Revenue Mix, 2012
Figure 28 Boehringer Ingelheim: Total Revenue ($Million) And Operating Margin (%), 2010 - 2012
Figure 29 Boehringer Ingelheim: Business Revenue Mix, 2012
Figure 30 Ceva: Total Revenue ($Million), 2010 - 2011
Figure 31 Heska: Total Revenue ($Million) And Operating Margin (%), 2010 - 2012
Figure 32 Heska: Business Revenue Mix, 2012
Figure 33 Heska: Geographic Revenue Mix, 2012
Figure 34 Merck: Total Revenue ($Million) And Operating Margin (%), 2010 - 2012
Figure 35 Merck Animal Health: Business Revenue Mix, 2011
Figure 36 Merck: Geographic Revenue Mix, 2011
Figure 37 Merck: Market Strategy, 2011 - 2013
Figure 38 Merial: Total Revenue ($Million), 2010 - 2012
Figure 39 Merial: Market Strategy, 2011 - 2013
Figure 40 Novartis: Total Revenue ($Million), 2010 - 2012
Figure 41 Novartis: Business Revenue Mix, 2012
Figure 42 Novartis: Geographic Revenue Mix, 2012
Figure 43 Virbac: Total Revenue ($Million), 2010 - 2012
Figure 44 Virbac: Business Revenue Mix, 2012
Figure 45 Virbac: Geographic Revenue Mix, 2012
Figure 46 Virbac, Market Strategy, 2011 - 2013
Figure 47 Zoetis: Total Revenue ($Million) And Operating Margin (%), 2010 - 2012
Figure 48 Zoetis: Business Revenue Mix, 2012
Figure 49 Zoetis: Geographic Revenue Mix, 2012
Figure 50 Zoetis, Market Strategy, 2011 - 2013

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

This cancer vaccines report by BCC Research explores present and future strategies within the market which includes prophylactic vaccines and therapeutic vaccines. Use this report to: - Analyze the global ...

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Veterinary Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

Veterinary vaccines are extensively used in the prevention of life-threatening animal diseases. This report on the global veterinary vaccines market analyzes the current and future prospects of the market. ...

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Human Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Human Vaccines Market: Scope and Methodology This report provides in-depth region wise and country wise analysis of the human vaccines market. Stakeholders of this report include manufacturers of human ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.